| Recruiting | Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative B NCT06324240 | Emory University | Phase 1 |
| Recruiting | Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV NCT05417308 | Ohio State University Comprehensive Cancer Center | EARLY_Phase 1 |
| Active Not Recruiting | STEMVAC in Patients With Early Stage Triple Negative Breast Cancer NCT05455658 | University of Washington | Phase 2 |
| Completed | Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivo NCT05674578 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Sta NCT05368428 | Emory University | N/A |
| Terminated | Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy NCT04835597 | M.D. Anderson Cancer Center | — |
| Withdrawn | Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Ca NCT05244434 | City of Hope Medical Center | N/A |
| Withdrawn | Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors NCT04560439 | City of Hope Medical Center | N/A |
| Recruiting | Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors NCT05452681 | University of Alabama at Birmingham | N/A |
| Recruiting | A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment NCT05243056 | University of Alabama at Birmingham | N/A |
| Recruiting | Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Pa NCT05092373 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer NCT05319873 | Jonsson Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Withdrawn | Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV T NCT05177796 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors NCT07259304 | University of Southern California | — |
| Completed | An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors NCT05012176 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer NCT05086731 | Emory University | N/A |
| Completed | Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel NCT04862585 | Ohio State University Comprehensive Cancer Center | Phase 2 / Phase 3 |
| Active Not Recruiting | Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stag NCT04754412 | M.D. Anderson Cancer Center | N/A |
| Active Not Recruiting | Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Sur NCT04906200 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer NCT04871516 | Rutgers, The State University of New Jersey | N/A |
| Completed | Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer NCT05071677 | M.D. Anderson Cancer Center | — |
| Terminated | Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients NCT04705025 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors NCT04999826 | Mayo Clinic | — |
| Withdrawn | Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer NCT04498520 | Pamela Munster | Phase 1 |
| Active Not Recruiting | T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Br NCT04457596 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Active Not Recruiting | Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions NCT04549571 | Alliance for Clinical Trials in Oncology | N/A |
| Recruiting | Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol NCT04771520 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation The NCT04927559 | University of Southern California | — |
| Completed | Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer NCT04205903 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Completed | Nipple Aspirate Fluid in Detecting Breast Cancer NCT03715959 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer NCT05025059 | M.D. Anderson Cancer Center | N/A |
| Withdrawn | Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal NCT04205071 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Completed | Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Bre NCT04535323 | Mayo Clinic | Phase 1 |
| Terminated | Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients Wit NCT04249622 | Mayo Clinic | Phase 2 |
| Terminated | RBX7455 Before Surgery for the Treatment of Operable Breast Cancer NCT04139993 | Mayo Clinic | Phase 1 |
| Recruiting | Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Ca NCT04090567 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and H NCT04876378 | University of California, San Francisco | — |
| Completed | Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer NCT04294225 | Mayo Clinic | Phase 2 |
| Completed | Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the T NCT04716920 | Thomas Jefferson University | N/A |
| Completed | Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Act NCT04200482 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With NCT04216472 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer NCT03554044 | University of California, San Francisco | Phase 1 |
| Withdrawn | Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer NCT04249167 | Mayo Clinic | EARLY_Phase 1 |
| Terminated | Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Ca NCT03979508 | Mayo Clinic | Phase 2 |
| Terminated | Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Patho NCT03872388 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer NCT04001829 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Completed | Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study NCT03707574 | National Cancer Institute (NCI) | — |
| Completed | Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Can NCT03207529 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer NCT04067960 | Mayo Clinic | EARLY_Phase 1 |
| Active Not Recruiting | Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer NCT03939481 | SWOG Cancer Research Network | — |
| Active Not Recruiting | Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer NCT04678414 | M.D. Anderson Cancer Center | — |
| Terminated | Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Sur NCT03751449 | Roswell Park Cancer Institute | N/A |
| Completed | Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors NCT04454086 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors NCT03725436 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With L NCT03786354 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Recep NCT04086875 | Thomas Jefferson University | N/A |
| Active Not Recruiting | PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutati NCT03218826 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Can NCT03666819 | Mayo Clinic | Phase 2 |
| Completed | Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Posi NCT03774472 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Can NCT03505671 | Wake Forest University Health Sciences | N/A |
| Completed | M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer NCT03620201 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer NCT03505736 | Wake Forest University Health Sciences | — |
| Completed | Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer NCT03518242 | Fred Hutchinson Cancer Center | Phase 1 |
| Completed | Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors NCT03523195 | Fred Hutchinson Cancer Center | N/A |
| Completed | IACS-010759 in Advanced Cancers NCT03291938 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative NCT03132467 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Completed | Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer NCT03106077 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With N NCT02918474 | M.D. Anderson Cancer Center | N/A |
| Active Not Recruiting | Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Ar NCT02971748 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant NCT05049746 | M.D. Anderson Cancer Center | N/A |
| Active Not Recruiting | Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer NCT01334021 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer NCT00507923 | M.D. Anderson Cancer Center | N/A |